Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Fabris

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Gut|July 25, 2014
Osteopontin: a new player in regulating hepatic ductular reaction and hepatic progenitor cell responses during chronic liver injuryMario Strazzabosco, Luca Fabris, Emanuele Albano
International Journal of Molecular Sciences|August 17, 2019
Cell Interactions in Biliary Diseases: Clues from Pathophysiology and Repair Mechanisms to Foster Early AssessmentLuca Fabris, Carlo Spirli, Joachim Mertens
Nature Reviews. Gastroenterology & Hepatology|October 11, 2024
Anticoagulants in cirrhosis: main concernsElena Campello, Luca Fabris, Paolo Simioni
Journal of Clinical Gastroenterology|March 11, 2005
Pathophysiology of cholangiopathiesMario Strazzabosco, Luca Fabris, Carlo Spirli
Journal of Hepatology|February 15, 2021
Illuminate TWEAK/Fn14 pathway in intrahepatic cholangiocarcinoma: Another brick in the wall of tumor nicheLuca Fabris, Massimiliano Cadamuro, Laura Fouassier
Hepatology (Baltimore, Md.)|August 8, 2024
Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary stricturesJesus M Banales, Ainhoa Lapitz, Luca Fabris
Journal of Gastroenterology and Hepatology|July 17, 2013
Vascular biology of the biliary epitheliumCarola M Morell, Luca Fabris, Mario Strazzabosco
Clinics and Research in Hepatology and Gastroenterology|March 6, 2019
Incretin-based treatment in type 2 diabetes mellitus and risk of cholangiocarcinoma: Is it only adverse drug effect?Gian Maria Barbato, Massimiliano Cadamuro, Luca Fabris
Journal of Hepatology|September 9, 2020
Intrahepatic cholangiocarcinoma: A single-cell resolution unraveling the complexity of the tumor microenvironmentLuca Fabris, Jesper B Andersen, Laura Fouassier
Journal of Clinical Medicine|December 26, 2015
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Simone Brivio, Massimiliano Cadamuro, Luca Fabris, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Gut|July 25, 2014
Osteopontin: a new player in regulating hepatic ductular reaction and hepatic progenitor cell responses during chronic liver injuryMario Strazzabosco, Luca Fabris, Emanuele Albano
International Journal of Molecular Sciences|August 17, 2019
Cell Interactions in Biliary Diseases: Clues from Pathophysiology and Repair Mechanisms to Foster Early AssessmentLuca Fabris, Carlo Spirli, Joachim Mertens
Nature Reviews. Gastroenterology & Hepatology|October 11, 2024
Anticoagulants in cirrhosis: main concernsElena Campello, Luca Fabris, Paolo Simioni
Journal of Clinical Gastroenterology|March 11, 2005
Pathophysiology of cholangiopathiesMario Strazzabosco, Luca Fabris, Carlo Spirli
Journal of Hepatology|February 15, 2021
Illuminate TWEAK/Fn14 pathway in intrahepatic cholangiocarcinoma: Another brick in the wall of tumor nicheLuca Fabris, Massimiliano Cadamuro, Laura Fouassier
Hepatology (Baltimore, Md.)|August 8, 2024
Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary stricturesJesus M Banales, Ainhoa Lapitz, Luca Fabris
Journal of Gastroenterology and Hepatology|July 17, 2013
Vascular biology of the biliary epitheliumCarola M Morell, Luca Fabris, Mario Strazzabosco
Clinics and Research in Hepatology and Gastroenterology|March 6, 2019
Incretin-based treatment in type 2 diabetes mellitus and risk of cholangiocarcinoma: Is it only adverse drug effect?Gian Maria Barbato, Massimiliano Cadamuro, Luca Fabris
Journal of Hepatology|September 9, 2020
Intrahepatic cholangiocarcinoma: A single-cell resolution unraveling the complexity of the tumor microenvironmentLuca Fabris, Jesper B Andersen, Laura Fouassier
Journal of Clinical Medicine|December 26, 2015
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Simone Brivio, Massimiliano Cadamuro, Luca Fabris, et al.
Pageof 13